Published in Biotech Business Week, February 27th, 2012
The acquisition of the IBM supercomputer is the second stage of an agreement between IBM and the University of Melbourne to provide next generation computational capacity for life sciences research within the VLSCI in conjunction with the IBM Research Collaboratory for Life Sciences-Melbourne.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.